Imperial College-London: Early Trials for 'Common Cold' Vaccine Offer Encouraging Signs
August 27, 2026
August 27, 2026
LONDON, England, Aug. 27 -- Imperial College-London issued the following news:
* * *
Early trials for 'common cold' vaccine offer encouraging signs
By Samantha Rey
A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a Phase 1 clinical trial.
Initial findings from the study found that the vacc . . .
* * *
Early trials for 'common cold' vaccine offer encouraging signs
By Samantha Rey
A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a Phase 1 clinical trial.
Initial findings from the study found that the vacc . . .